Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • NCD 2025
NET Nurse
Donate

Home » News » NET Patient Rob Hammond speaks at the Senate Inquiry hearing in Tasmania

NET Patient Rob Hammond speaks at the Senate Inquiry hearing in Tasmania

  • February 20, 2024

NET Patient and passionate advocate and fundraiser Rob Hammond shared his story and the plight of NET Patients Australia wide at the Senate Inquiry into “Equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer” in Hobart on February 20.

Rob spoke about the challenges around accessing optimal care and the inequities that NET patients face living in Tasmania, including referral pathways, HCP education and low awareness of the disease amongst the general public and healthcare professional community. He touched on the challenges he has faced during this advocacy work and thanked Senator Wendy Askew for the opportunity to speak and feel heard. Thank you Rob for sharing not only your own story, but one that will resonate with so many Tasmanian and NET patients and indeed patients Australia wide. 

Listen to Robs full speech here. 

 

Share this post

Recent posts

Nuclear Medicine Round Table

November 27, 2025

Celebrated Chef and Slow Food Pioneer Skye Gyngell Passed Away from Neuroendocrine Cancer

November 27, 2025

Attribute Preferences for SSAs in NETs Among Patients, Clinicians and Nurses in Australia

November 26, 2025

NECA Christmas and New Year Closure Details

November 18, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousNECA presents alongside Peter MacCallum Cancer Centre at the Senate Inquiry
NextTamworth local Ryan Harding advocates for VHL patients to have access to BelzutifanNext

Related Posts

Nuclear Medicine Round Table

On Monday 17 November NECA attended the National Roundtable – Sustainable Pathways: Shaping the Future of Nuclear Medicines in Australia at Parliament House. Nuclear Medicine

Celebrated Chef and Slow Food Pioneer Skye Gyngell Passed Away from Neuroendocrine Cancer

Australian born chef Skye Gyngell, one of the most influential voices in the slow food movement and a pioneer of seasonal, sustainable cooking, has died

NECA Christmas and New Year Closure Details

Ten tips during the holiday season. Neuroendocrine Cancer Australia advises holiday closure dates effective COB Tuesday 23 December 2025 to Friday 2 January 2026 inclusive.

Neuroendocrine Cancer Day 2025

On Monday November 10, our incredible NET community came together to mark Neuroendocrine Cancer Day, a day dedicated to raising awareness and recognising everyone affected

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin